Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cooper

Showing results (251-260 of 319) with videos related to

Pageof 32
Sort By:
The Lancet. HIV|January 9, 2017
Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trialJemma O'Connor, Michael J Vjecha, Andrew N Phillips, et al.
Vaccine|November 22, 2016
Safety, tolerability, and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults: Results of a randomised trialC Buddy Creech, Robert W Frenck, Eric A Sheldon, et al.
Plos Medicine|March 29, 2021
Evaluation of the Arabin cervical pessary for prevention of preterm birth in women with a twin pregnancy and short cervix (STOPPIT-2): An open-label randomised trial and updated meta-analysisJane E Norman, John Norrie, Graeme MacLennan, et al.
Preventive Veterinary Medicine|January 19, 2021
Optimisation of the tuberculin skin test for detection of Mycobacterium bovis in African buffaloes (Syncerus caffer)Katrin Smith, Netanya Bernitz, David Cooper, et al.
AIDS (London, England)|October 3, 2003
Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trialJintanat Ananworanich, Reto Nuesch, Michelle Le Braz, et al.
Trials|December 13, 2025
Effectiveness and cost-effectiveness of a peer-delivered, relational, harm reduction intervention to improve mental health, quality of life, and related outcomes, for people experiencing homelessness and substance use problems: protocol for the 'SHARPS' cluster randomised controlled trialTessa Parkes, Hannah Carver, Jennifer Boyd, et al.
Health Technology Assessment (Winchester, England)|December 5, 2018
Bariatric surgery, lifestyle interventions and orlistat for severe obesity: the REBALANCE mixed-methods systematic review and economic evaluationAlison Avenell, Clare Robertson, Zoë Skea, et al.
Nucleic Acids Research|January 12, 2026
Presence of phosphodiester backbone, but not nucleobases, in the guide's 3' terminal region is necessary for RISC loading and target cleavage in vitro and in vivoDaniel O'Reilly, Raymond C Furgal, Vella M Ross, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 28, 2023
A Bivalent Omicron-BA.4/BA.5-Adapted BNT162b2 Booster in ≥12-Year-OldsLisa Usdan, Sohil Patel, Hector Rodriguez, et al.
Vaccine|February 25, 2025
A phase 2/3 trial to investigate the safety and immunogenicity of monovalent Omicron JN.1-adapted BNT162b2 COVID-19 vaccine in adults ≥18 years oldOyeniyi Diya, Juleen Gayed, Francine S Lowry, et al.
Pageof 32

Showing results (251-260 of 319) with videos related to

Sort By:
Pageof 32
The Lancet. HIV|January 9, 2017
Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trialJemma O'Connor, Michael J Vjecha, Andrew N Phillips, et al.
Vaccine|November 22, 2016
Safety, tolerability, and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults: Results of a randomised trialC Buddy Creech, Robert W Frenck, Eric A Sheldon, et al.
Plos Medicine|March 29, 2021
Evaluation of the Arabin cervical pessary for prevention of preterm birth in women with a twin pregnancy and short cervix (STOPPIT-2): An open-label randomised trial and updated meta-analysisJane E Norman, John Norrie, Graeme MacLennan, et al.
Preventive Veterinary Medicine|January 19, 2021
Optimisation of the tuberculin skin test for detection of Mycobacterium bovis in African buffaloes (Syncerus caffer)Katrin Smith, Netanya Bernitz, David Cooper, et al.
AIDS (London, England)|October 3, 2003
Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trialJintanat Ananworanich, Reto Nuesch, Michelle Le Braz, et al.
Trials|December 13, 2025
Effectiveness and cost-effectiveness of a peer-delivered, relational, harm reduction intervention to improve mental health, quality of life, and related outcomes, for people experiencing homelessness and substance use problems: protocol for the 'SHARPS' cluster randomised controlled trialTessa Parkes, Hannah Carver, Jennifer Boyd, et al.
Health Technology Assessment (Winchester, England)|December 5, 2018
Bariatric surgery, lifestyle interventions and orlistat for severe obesity: the REBALANCE mixed-methods systematic review and economic evaluationAlison Avenell, Clare Robertson, Zoë Skea, et al.
Nucleic Acids Research|January 12, 2026
Presence of phosphodiester backbone, but not nucleobases, in the guide's 3' terminal region is necessary for RISC loading and target cleavage in vitro and in vivoDaniel O'Reilly, Raymond C Furgal, Vella M Ross, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 28, 2023
A Bivalent Omicron-BA.4/BA.5-Adapted BNT162b2 Booster in ≥12-Year-OldsLisa Usdan, Sohil Patel, Hector Rodriguez, et al.
Vaccine|February 25, 2025
A phase 2/3 trial to investigate the safety and immunogenicity of monovalent Omicron JN.1-adapted BNT162b2 COVID-19 vaccine in adults ≥18 years oldOyeniyi Diya, Juleen Gayed, Francine S Lowry, et al.
Pageof 32